Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.

BMC immunology - 22 Jul 2021

Kolou Malewe, Poda Armel, Diallo Zelica, Konou Esther, Dokpomiwa Tatiana, Zoungrana Jacques, Salou Mounerou, Mba-Tchounga Lionèle, Bigot André, Ouedraogo Abdoul-Salam, Bouyout-Akoutet Marielle, Ekouevi Didier K, Eholie Serge P

Abstract excerpt

BACKGROUND: The presence of the human leukocyte antigen HLA-B*57:01 is associated with the development of a hypersensitivity reaction to abacavir (ABC). Limited data exist on HLA-B*57:01 prevalence in individuals with HIV-1 in Africa. This study aimed to estimate HLA-B*57:01 prevalence in individuals with HIV-1 in West and Central Africa. METHODS: A cross-sectional study was conducted in four countries in West...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Africa, Central

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Africa, Western

Share to Dideoxynucleosides

Share to Drug Hypersensitivity

Share to HIV Infections

Share to HLA-B Antigens

Source

Open in PubMed Open full text

Identifiers

PMID: 34294032
DOI: 10.1186/s12865-021-00427-7
PMCID: PMC8299582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.PMID 34294032Read ↗

Prevalence of Human Leukocyte Antigen HLA-B*57:01 in Individuals with HIV in West and Central AfricaSemantic proximity Read ↗

Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers in People Living with HIV/AIDS in Türkiye.Semantic proximity Read ↗

High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.Semantic proximity Read ↗

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjectsSemantic proximity Read ↗

Prevalence of HLA-B*57:01 and complete linkage disequilibrium with HCP5 rs2395029: Prevalence and DetectionSemantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot studySemantic proximity Read ↗

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.Semantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study.Semantic proximity Read ↗

HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV.Semantic proximity Read ↗

Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.Semantic proximity Read ↗

Full-length next-generation sequencing of 11 HLA loci of more than 1000 individuals from clinical cohorts in East and West AfricaSemantic proximity Read ↗

HLA-B*5701 Allele Prevalence in Treatment-Naïve HIV-Infected Patients from ColombiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.